|
PPIP5K2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52697999999951E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83409999999773E-05 |
| Normal-vs-Stage2 |
6.083500E-03 |
| Normal-vs-Stage3 |
2.478100E-02 |
| Normal-vs-Stage4 |
2.868000E-02 |
| Stage1-vs-Stage2 |
4.948800E-01 |
| Stage1-vs-Stage3 |
2.097000E-01 |
| Stage1-vs-Stage4 |
7.395600E-02 |
| Stage2-vs-Stage3 |
1.832170E-01 |
| Stage2-vs-Stage4 |
1.174640E-01 |
| Stage3-vs-Stage4 |
7.693000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70520999999146E-05 |
| Normal-vs-AfricanAmerican |
7.051900E-02 |
| Normal-vs-Asian |
9.247700E-02 |
| Caucasian-vs-AfricanAmerican |
2.322800E-01 |
| Caucasian-vs-Asian |
9.478000E-01 |
| AfricanAmerican-vs-Asian |
6.915000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.74239999999726E-05 |
| Normal-vs-Female |
4.196900E-04 |
| Male-vs-Female |
8.404200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.060200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.97520000000595E-05 |
| Normal-vs-Age(61-80Yrs) |
2.634800E-04 |
| Normal-vs-Age(81-100Yrs) |
5.687700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.104300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.253010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.316760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.265400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.773200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.033600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.729520E-02 |
| Normal-vs-Grade 2 |
2.40309999999244E-06 |
| Normal-vs-Grade 3 |
1.623100E-04 |
| Normal-vs-Grade 4 |
7.652000E-01 |
| Grade 1-vs-Grade 2 |
5.690800E-01 |
| Grade 1-vs-Grade 3 |
7.944600E-01 |
| Grade 1-vs-Grade 4 |
1.113370E-01 |
| Grade 2-vs-Grade 3 |
1.029790E-01 |
| Grade 2-vs-Grade 4 |
2.246600E-04 |
| Grade 3-vs-Grade 4 |
7.778200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.29660000408794E-08 |
| Normal-vs-ccB subtype |
4.352400E-02 |
| ccA subtype-vs-ccB subtype |
1.059110E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.13400000000208E-05 |
| Normal-vs-N1 |
7.525800E-01 |
| N0-vs-N1 |
2.809600E-01 |
|
|
